Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles

Among various immunotherapies, natural killer (NK) cell cancer immunotherapy using adoptive transfer of NK cells takes a unique position by targeting tumor cells that evade the host immune surveillance. As the first-line innate effector cell, it has been revealed that NK cells have distinct mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwang-Soo, Kim, Dong-Hwan, Kim, Dong-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069998/
https://www.ncbi.nlm.nih.gov/pubmed/33918941
http://dx.doi.org/10.3390/pharmaceutics13040525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069998/
https://www.ncbi.nlm.nih.gov/pubmed/33918941
http://dx.doi.org/10.3390/pharmaceutics13040525

Ejemplares similares